Alaleh Nouri - 19 Feb 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: EVP, CLO, CORP. SEC.
Signature: /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
Issuer symbol: PRCT
Transactions as of: 19 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 25 Feb 2026, 16:47:31 UTC
Previous filing: 14 Aug 2025
Next filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nouri Alaleh	EVP, CLO, CORP. SEC.	C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE	/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri	25 Feb 2026	0001599418

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Award	$0	+4,872	+6.7%	$0.000000	77,345	19 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock.

Content

Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock.